Transformation of Health Care Technologies by IBM, Apple, Johnson & Johnson and Medtronic

August 10, 2015 by 2012pharmaceutical

IBM Announces Deals With Apple, Johnson & Johnson, and Medtronic In Bid To Transform Health Care by Matthew Herper, Forbes Staff

Reporter: Aviva Lev-Ari, PhD, RN

Big Blue is certainly putting some muscle into medicine. Some 2,000 employees will be involved in a new Watson-in-medicine business unit. The Armonk, N.Y.-based computing giant is making two acquisitions, too, buying Cleveland’s Explorys, an analytics company that has access to 50 million medical records from U.S. patients, and Dallas’ Phytel, a healthcare services head of IBM’s Life Science company that provides feedback to doctors and patients for follow-up care. Deal prices were not disclosed.

It is also announcing some big partnerships:
• Apple AAPL +3.6% will work to integrate Watson-based apps into its HealthKit and ResearchKit tool systems for developers, which allow the collection of personal health data and the use of such data in clinical trials.

• Johnson & Johnson JNJ +0.95%, which is one of the largest makers of knee and hip implants, will use Watson to create a personal concierge service to prepare patients for knee surgery and to help them deal with its after effects.

• Medtronic MDT +0.18%, the maker of implantable heart devices and diabetes products, will use Watson to create an “internet of things” around its medical gadgets, collecting data both for patients’ personal use and, once it’s anonymized, for understanding how well the devices are working. Initially, the focus is on diabetes.

SOURCE

http://www.forbes.com/sites/matthewherper/2015/04/13/ibm-announces-deals-with-apple-johnson-johnson-and-medtronic-in-bid-to-transform-health-care/

Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Funding, Deals & Partnerships: BIOLOGICS & MEDICAL DEVICES; BioMed e-Series; Medicine and Life Sciences Scientific Journal – http://PharmaceuticalIntelligence.com